New breast cancer drug launched in UK
A new drug has been launched for women with advanced HER2-positive breast cancer who have stopped responding to trastuzumab (Herceptin).
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units